News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

February 2015

Improving the Value of Immune-Based Therapies

ByRichard W. Joseph, MD

February 16th 2015

Issues Impacting Stakeholder Adoption of Immuno-Oncology

ByBruce Feinberg, DO

February 16th 2015

New Standards of Care in the Management of Prostate Cancer

BySurabhi Dangi-Garimella, PhD

February 16th 2015

Payers Evaluate the Clinical Utility of Diagnostic Tests

BySurabhi Dangi-Garimella, PhD

February 16th 2015

Innovation and the Role of Alternative Markers of Efficacy

BySejal Saraiya, PharmD

February 16th 2015

The Use and Implementation of Standardized Treatment Pathways

BySejal Saraiya, PharmD

February 16th 2015

Arguments Taking Shape For and Against FDA Regulation of Diagnostic Tests

ByMary K. Caffrey

February 16th 2015

HHS Announces New Oncology Care Management Initiative

ByLaura Joszt, MA

February 16th 2015

FDA Updates

BySurabhi Dangi-Garimella, PhD

February 16th 2015

Study Results Support Early Treatment With Abiraterone in Prostate Cancer

BySurabhi Dangi-Garimella, PhD

February 16th 2015

ASCO Announces Partner for CancerLinQ Platform

ByMary K. Caffrey

February 16th 2015

ASCO Demands Medicaid Reform

BySurabhi Dangi-Garimella, PhD

February 16th 2015

FDA Approves Palbociclib for Metastatic Breast Cancer

February 16th 2015

Reality Meets ASCO's Policy Statement on Medicaid Reform

ByTed Okon, MBA

February 16th 2015

Patient Cost-Sharing in Oncology and the Patient Access Network Foundation

February 16th 2015

Commission on Cancer and the Oncology Medical Home

ByDaniel P. McKellar, MD, FACS

February 15th 2015

Immuno-Oncology Poised to Revolutionize Patient Care

ByLee S. Schwartzberg, MD, FACP

February 15th 2015

The Promise of Immuno-Oncology

BySurabhi Dangi-Garimella, PhD

February 15th 2015

Money Well Spent: the Need for Federal Funding in Cancer Research

ByJohn R. Seffrin, PhD

February 15th 2015

Trending on AJMC

Elinzanetant Shows Consistent Efficacy, Safety, and Sleep Benefits Across Studies

Tirzepatide Plus Hormone Therapy Boosts Weight Loss in Menopause: Regina Castaneda, MD

How Can Trauma Affect the Menopausal Transition?

Elinzanetant Shows Strong 52-Week Safety for Vasomotor Symptoms: James Simon, MD

GLP-1 Receptor Agonists May Improve Rheumatoid Arthritis Symptoms

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.